To determine the role of cardiomyocyte Oga deficiency during HF, tamoxifen treated male icmOga+/+ and icmOga+/- mice were subjected to MI at 12–20 wk old and followed for 1 wk (see timeline in S1C Fig). This evidence concerns the gene OGA and myocardial infarction.